QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
NASDAQ:ENVB

Enveric Biosciences (ENVB) News Today

Notice: Trading of Enveric Biosciences halted at 09:37 AM EST due to "LULD pause".
$3.59
+2.07 (+136.18%)
(As of 05/18/2023 ET)
Compare
Today's Range
$2.02
▼
$4.49
50-Day Range
$1.33
▼
$2.06
52-Week Range
$1.30
▼
$18.50
Volume
119.39 million shs
Average Volume
1.30 million shs
Market Capitalization
$7.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$43.75
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media
Get Enveric Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENVB and its competitors with MarketBeat's FREE daily newsletter.



ENVB Media Mentions By Week

ENVB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ENVB
News Sentiment
▼
0.21

0.34
▲
Average
Medical
News Sentiment

ENVB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ENVB Articles
This Week
▼
6

0
▲
ENVB Articles
Average Week

SourceHeadline
msn.com logoEnveric Bio Stock Spikes 115% After Its Novel Prodrug Of Psilocin Receives Notice Of Allowance From US Patent And Trademark Office
msn.com - May 18 at 6:46 PM
theglobeandmail.com logoEnveric Biosciences (NASDAQ: ENVB) Obtains Notice of Allowance For a U.S. Patent Covering Its Innovative Psilocin Prodrug, EB-373
theglobeandmail.com - May 18 at 1:46 PM
msn.com logoEnveric Skyrockets on Bagging Notice of Allowance from USPTO for Lead Candidate
msn.com - May 18 at 1:46 PM
marketbeat.com logo
marketbeat.com - May 18 at 9:38 AM
finance.yahoo.com logoEnveric Biosciences Receives Notice of Allowance from USPTO for Novel Prodrug of Psilocin
finance.yahoo.com - May 18 at 8:46 AM
msn.com logoEnveric Biosciences Q1 Net Loss Of $4.80M, More On Basic And Diluted Loss Per Share
msn.com - May 15 at 7:19 PM
markets.businessinsider.com logoEXCLUSIVE: Reinventing Mental Health & Next-Gen Psychedelics, 'Access And Clinical Data Are Key'
markets.businessinsider.com - April 14 at 1:05 PM
finance.yahoo.com logoEnveric Biosciences to Participate in Benzinga Psychedelics Capital Conference
finance.yahoo.com - April 10 at 8:03 AM
finance.yahoo.com logoEnveric Biosciences Reports Fourth Quarter and Year-End 2022 Corporate and Financial Results
finance.yahoo.com - April 3 at 4:16 PM
MarketBeat logoEnveric Biosciences (ENVB) Set to Announce Earnings on Wednesday
americanbankingnews.com - March 28 at 9:48 AM
finance.yahoo.com logoEnveric Biosciences Selects Australian CRO, Avance Clinical, in Preparation for Phase 1 Study of EB-373
finance.yahoo.com - March 23 at 8:11 AM
finance.yahoo.com logoEnveric Biosciences Establishes Australia-based Subsidiary to Accelerate its Lead Psilocin Prodrug Program Targeting Mental Health Indications
finance.yahoo.com - March 21 at 8:29 AM
benzinga.com logoEnveric Biosciences: Novel Next-Gen Drug Discovery Platform Includes Rare Toad Enzyme
benzinga.com - March 14 at 5:06 PM
finance.yahoo.com logoEnveric Biosciences Appoints Kevin Coveney as Chief Financial Officer, and Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
finance.yahoo.com - February 28 at 12:34 PM
finance.yahoo.com logoEnveric Biosciences Names Lynn Gallant Vice President, Clinical Operations, and Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
finance.yahoo.com - February 23 at 2:41 PM
seekingalpha.com logoENVB Enveric Biosciences, Inc.
seekingalpha.com - February 22 at 3:34 PM
finance.yahoo.com logoEnveric Biosciences to Present at the Gravitas Securities Inc. 6th Annual Growth Conference
finance.yahoo.com - February 22 at 3:34 PM
finance.yahoo.com logoEnveric Biosciences to Present at the BIO CEO & Investor Conference
finance.yahoo.com - February 1 at 8:33 AM
finance.yahoo.com logoEnveric Biosciences to Present at the 6th Annual Neuroscience Innovation Forum and Biotech Showcase during "J.P. Morgan Health Care Week 2023"
finance.yahoo.com - December 21 at 12:32 PM
finance.yahoo.com logoEnveric Biosciences to Participate in A.G.P.’s Virtual Biotech Conference
finance.yahoo.com - November 16 at 6:36 PM
finance.yahoo.com logoEnveric Biosciences to Participate in Wonderland: Miami on November 3-5, 2022
finance.yahoo.com - November 1 at 8:18 AM
finance.yahoo.com logoEnveric Biosciences Advances Lead Candidate for the Treatment of Anxiety Disorders to IND-Enabling Studies
finance.yahoo.com - October 24 at 7:22 AM
finance.yahoo.com logoEnveric Biosciences Announces Poster Presentations of Lead Programs at the 2022 International Neurology & Brain Disorders Conference
finance.yahoo.com - October 12 at 8:53 AM
finance.yahoo.com logoEnveric Biosciences to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022
finance.yahoo.com - August 31 at 10:31 AM
finanznachrichten.de logoMicrosmallcap.com: Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression
finanznachrichten.de - August 10 at 10:37 AM
marketbeat.com logo
marketbeat.com - August 3 at 3:45 PM
marketbeat.com logo
marketbeat.com - August 3 at 3:37 PM
marketbeat.com logo
marketbeat.com - August 3 at 3:30 PM
uk.investing.com logoEnveric Biosciences Stock Is Nosediving Today: What's Happening?
uk.investing.com - July 27 at 8:29 PM
finance.yahoo.com logoEnveric Biosciences Announces Closing of $8 Million Registered Direct and Private Placement Offerings, Priced at a Premium to Market Under Nasdaq Rules
finance.yahoo.com - July 26 at 8:11 PM
finance.yahoo.com logoEnveric Biosciences Announces $8 Million Registered Direct Offering and Private Placement, Priced at a Premium to Market Under Nasdaq Rules
finance.yahoo.com - July 25 at 8:27 AM
finance.yahoo.com logoEnveric Biosciences Announces Reverse Stock Split
finance.yahoo.com - July 14 at 4:27 PM
finance.yahoo.com logoEnveric Biosciences to Participate in Upcoming Conferences in June 2022
finance.yahoo.com - June 8 at 9:53 AM
finance.yahoo.com logoEnveric Biosciences to Participate in the Microdose Psychedelic Capital Conference on May 26, 2022
finance.yahoo.com - May 24 at 7:36 PM
finance.yahoo.com logoEnveric Biosciences to Participate in the H.C. Wainwright Global Investment Conference on May 23-26, 2022
finance.yahoo.com - May 17 at 3:46 PM
msn.com logoEXCLUSIVE: NASDAQ-Listed Enveric To Split Into Two Companies, One For Cannabinoids, One For Psychedelics
msn.com - May 11 at 8:59 AM
finanznachrichten.de logoMicrosmallcap.com: American Billionaire Entrepreneurs Bet Millions on Psychedelics
finanznachrichten.de - May 10 at 12:36 PM
benzinga.com logoAmerican Billionaire Entrepreneurs Bet Millions on Psychedelics
benzinga.com - May 10 at 12:36 PM
finance.yahoo.com logoEnveric Biosciences to Host Fireside Chat with Dr. Bob Dagher, Chief Medical Officer, on May 17th at 10:00 a.m. ET
finance.yahoo.com - May 5 at 8:28 AM
finance.yahoo.com logoEnveric Biosciences Announces Distribution of Series C Preferred Stock to Holders of its Common Stock
finance.yahoo.com - May 3 at 5:50 PM
finance.yahoo.com logoEXCLUSIVE: Enveric Offers Investors Rare Exposure To Both Cannabis And Psychedelic Industries
finance.yahoo.com - April 19 at 11:31 PM
finance.yahoo.com logoEnveric Biosciences to Participate in Upcoming Investor Conferences in April 2022
finance.yahoo.com - April 14 at 10:23 AM
seekingalpha.com logoEnveric Biosciences GAAP EPS of -$2.07 misses by $1.56
seekingalpha.com - March 31 at 9:57 PM
finance.yahoo.com logoEnveric Biosciences Reports Full-Year 2021 Financial Results and Provides Business Update
finance.yahoo.com - March 31 at 9:57 PM
finance.yahoo.com logoEnveric Biosciences Expands Portfolio of Drug Development Candidates and Files New Provisional Patent Application
finance.yahoo.com - March 29 at 9:10 AM
proactiveinvestors.com logoEnveric Biosciences touts the publication of four patent applications for psychedelic-inspired drug candidates
proactiveinvestors.com - March 15 at 1:20 PM
proactiveinvestors.com logoEnveric Biosciences unveils publication of four patent applications for psychedelic-inspired drug candidates
proactiveinvestors.com - March 15 at 1:20 PM
benzinga.com logoEnveric Biosciences (NASDAQ: ENVB)
benzinga.com - March 9 at 8:32 PM
finance.yahoo.com logoEnveric Biosciences to Participate in Upcoming Investor Conferences in March 2022
finance.yahoo.com - March 3 at 8:29 AM
proactiveinvestors.com logoEnveric Biosciences files portfolio of patent applications for tryptamine derivatives
proactiveinvestors.com - March 1 at 7:50 PM
Get Enveric Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENVB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:ENVB) was last updated on 5/18/2023 by MarketBeat.com Staff

My Account -